A new precision radiotherapy technique described as ‘practice changing’ has been shown to reduce long-term side effects, including swallowing problems, for patients with head and neck cancer following treatment.

A drug combination targeting multiple mutant versions of cancer’s ‘death star’ protein has shown promise in a small, early-phase clinical trial for some patients with advanced lung, ovarian and thyroid cancer.

Screening people’s genomes as part of routine primary care can spot genetic changes that may have important implications for health, a new study reports.